Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (RIG2) - Total Assets
Based on the latest financial reports, Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (RIG2) holds total assets worth €1.60 Trillion EUR (≈ $1.87 Trillion USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt - Total Assets Trend (2013–2025)
This chart illustrates how Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's total assets have evolved over time, based on quarterly financial data. Also see Richter Gedeon Vegyészeti Gyár Nyilvános market capitalisation for the company's overall valuation and market capitalisation.
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt - Asset Composition Analysis
Current Asset Composition (December 2025)
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's total assets of €1.60 Trillion consist of 45.9% current assets and 54.1% non-current assets. Review RIG2 current and long-term liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 12.5% |
| Accounts Receivable | €244.40 Billion | 14.4% |
| Inventory | €214.11 Billion | 12.6% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €293.43 Billion | 17.3% |
| Goodwill | €42.16 Billion | 2.5% |
Asset Composition Trend (2013–2025)
This chart illustrates how Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Richter Gedeon Vegyészeti Gyár Nyilvános stock quote for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's current assets represent 45.9% of total assets in 2025, an increase from 41.9% in 2013.
- Cash Position: Cash and equivalents constituted 12.5% of total assets in 2025, down from 14.9% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 19.0% of total assets, a decrease from 27.0% in 2013.
- Asset Diversification: The largest asset category is intangible assets at 17.3% of total assets.
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Competitors by Total Assets
Key competitors of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Viatris Inc
NASDAQ:VTRS
|
USA | $35.04 Billion |
|
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521
|
China | CN¥22.22 Billion |
|
Beijing Tongrentang Co Ltd
SHG:600085
|
China | CN¥31.82 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS
IS:ECILC
|
Turkey | TL70.69 Billion |
|
Heilongjiang ZBD Pharmaceutical Co Ltd
SHG:603567
|
China | CN¥10.50 Billion |
|
Teyi Pharmaceutical Group Co Ltd
SHE:002728
|
China | CN¥2.33 Billion |
|
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799
|
China | CN¥2.53 Billion |
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.93 | 3.26 | 4.21 |
| Quick Ratio | 2.66 | 2.03 | 3.17 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €514.21 Billion | €378.58 Billion | €347.78 Billion |
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt - Advanced Valuation Insights
This section examines the relationship between Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.69 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 5.7% |
| Total Assets | €1.70 Trillion |
| Market Capitalization | $6.56 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's assets grew by 5.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (2013–2025)
The table below shows the annual total assets of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €1.70 Trillion ≈ $1.99 Trillion |
+5.66% |
| 2024-12-31 | €1.61 Trillion ≈ $1.88 Trillion |
+18.07% |
| 2023-12-31 | €1.36 Trillion ≈ $1.59 Trillion |
+1.56% |
| 2022-12-31 | €1.34 Trillion ≈ $1.57 Trillion |
+17.03% |
| 2021-12-31 | €1.15 Trillion ≈ $1.34 Trillion |
+20.74% |
| 2020-12-31 | €948.59 Billion ≈ $1.11 Trillion |
+10.47% |
| 2019-12-31 | €858.65 Billion ≈ $1.00 Trillion |
+7.62% |
| 2018-12-31 | €797.88 Billion ≈ $932.81 Billion |
+4.87% |
| 2017-12-31 | €760.87 Billion ≈ $889.53 Billion |
-6.51% |
| 2016-12-31 | €813.88 Billion ≈ $951.51 Billion |
+8.95% |
| 2015-12-31 | €746.99 Billion ≈ $873.31 Billion |
+3.74% |
| 2014-12-31 | €720.06 Billion ≈ $841.82 Billion |
+0.83% |
| 2013-12-31 | €714.14 Billion ≈ $834.91 Billion |
-- |
About Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. It offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids; and Femtech, a digital therapeutic solution to enhance women's lives. It also provides central nervous system products, such as products for the treatment of chron… Read more